ALSO NOTED: PA health plan merger turns on exec salary disclosures; second Medtronic case heard by the Supreme Court; and much
> The blockbuster merger between Pennsylvania health plans Independence Blue Cross and Highmark may turn on how forthright executives are about their future pay--and whether insurance officials like what they say. Article
> The U.S. Supreme Court will soon hear the much-watched case against device-maker Medtronic, which is arguing that it shouldn't face state claims over failures of its technology. Article
> New research may give Avandia yet another black eye. In addition to causing heart troubles, it seems that the drug may also increase osteoporosis risk. Article
> In a sobering development, federal health officials are substantially boosting their estimate of how many people are infected by HIV each year. Article
And Finally... This guy was a really fast dinosaur. (But wouldn't you be if T-Rex was after you?) Article
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies




